GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (HKSE:06821) » Definitions » Change In Receivables

Asymchem Laboratories Tianjin Co (HKSE:06821) Change In Receivables : HK$0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Asymchem Laboratories Tianjin Co Change In Receivables?

Asymchem Laboratories Tianjin Co's change in receivables for the quarter that ended in Mar. 2025 was HK$0 Mil. It means Asymchem Laboratories Tianjin Co's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Asymchem Laboratories Tianjin Co's change in receivables for the fiscal year that ended in Dec. 2024 was HK$112 Mil. It means Asymchem Laboratories Tianjin Co's Accounts Receivable declined by HK$112 Mil from Dec. 2023 to Dec. 2024 .

Asymchem Laboratories Tianjin Co's Accounts Receivable for the quarter that ended in Mar. 2025 was HK$1,784 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Asymchem Laboratories Tianjin Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 98.49.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Asymchem Laboratories Tianjin Co's liquidation value for the three months ended in Mar. 2025 was HK$7,672 Mil.


Asymchem Laboratories Tianjin Co Change In Receivables Historical Data

The historical data trend for Asymchem Laboratories Tianjin Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asymchem Laboratories Tianjin Co Change In Receivables Chart

Asymchem Laboratories Tianjin Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -500.05 -1,300.53 -654.53 547.80 112.35

Asymchem Laboratories Tianjin Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Asymchem Laboratories Tianjin Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asymchem Laboratories Tianjin Co  (HKSE:06821) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Asymchem Laboratories Tianjin Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1783.633/1652.513*91
=98.49

2. In Ben Graham's calculation of liquidation value, Asymchem Laboratories Tianjin Co's accounts receivable are only considered to be worth 75% of book value:

Asymchem Laboratories Tianjin Co's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=8112.835-2414.677+0.75 * 1783.633+0.5 * 1272.857
=7,672

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Asymchem Laboratories Tianjin Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Asymchem Laboratories Tianjin Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Asymchem Laboratories Tianjin Co Business Description

Traded in Other Exchanges
Address
No. 6 Dongting Third Street, Economic and Technological Development Zone, Tianjin, CHN, 300457
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development manufacturing organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Citigroup Inc. 2201 Interest of corporation controlled by you
Schroders Plc 2102 Investment manager
Norges Bank 2101 Beneficial owner
Fmr Llc 2201 Interest of corporation controlled by you
Fidelity Investment Trust 2101 Beneficial owner
Springhill Fund Asset Management (hk) Company Limited 2102 Investment manager
Springhill Fund Limited 2201 Interest of corporation controlled by you
Springhill Global Feeder Fund Limited 2201 Interest of corporation controlled by you
Springhill Master Fund Limited 2101 Beneficial owner
Morgan Stanley 2201 Interest of corporation controlled by you
Hhlr Advisors, Ltd. 2102 Investment manager
Hhlr Fund, L.p. 2101 Beneficial owner
Jpmorgan Asset Management (asia Pacific) Limited 2102 Investment manager
Fidelity Management & Research Company Llc

Asymchem Laboratories Tianjin Co Headlines

No Headlines